Variant report
Variant | nsv1124 |
---|---|
Chromosome Location | chr13:93242968-93289282 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:93245624..93248556-chr13:93249353..93251806,3 | K562 | blood: | |
2 | chr13:93245624..93248556-chr13:93249353..93251806,3 | K562 | blood: | |
3 | chr13:93273565..93275708-chr13:93279729..93281510,2 | K562 | blood: | |
4 | chr13:93281680..93284628-chr13:93314114..93316635,2 | K562 | blood: | |
5 | chr13:93273565..93275708-chr13:93279729..93281510,2 | K562 | blood: | |
6 | chr13:93228704..93231280-chr13:93244636..93246589,2 | K562 | blood: | |
7 | chr13:93239441..93241282-chr13:93243358..93246223,2 | K562 | blood: | |
8 | chr13:93281728..93283800-chr13:93286450..93288614,2 | K562 | blood: | |
9 | chr13:93281728..93283800-chr13:93286450..93288614,2 | K562 | blood: | |
10 | chr13:93282740..93284834-chr13:93292372..93295262,2 | K562 | blood: | |
11 | chr13:93289108..93290701-chr13:93292511..93295289,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs56106244 | chr13:93242974-93242975 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs79211193 | chr13:93242975-93242976 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548452997 | chr13:93242988-93242989 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191728425 | chr13:93242994-93242995 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114880198 | chr13:93243049-93243050 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376046244 | chr13:93243050-93243051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553652829 | chr13:93243091-93243092 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146920828 | chr13:93243105-93243106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370013243 | chr13:93243111-93243112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369383085 | chr13:93243137-93243138 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539893326 | chr13:93243175-93243176 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556640188 | chr13:93243210-93243211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576492491 | chr13:93243227-93243228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184017042 | chr13:93243256-93243257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556003307 | chr13:93243294-93243295 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572622453 | chr13:93243301-93243302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75936070 | chr13:93243349-93243350 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564477976 | chr13:93243351-93243352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147982843 | chr13:93243366-93243367 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533603242 | chr13:93243380-93243381 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201945022 | chr13:93243416-93243417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373040589 | chr13:93243459-93243460 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562178788 | chr13:93243489-93243490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375085974 | chr13:93243493-93243494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531189861 | chr13:93243505-93243506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9556194 | chr13:93243514-93243515 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs568361723 | chr13:93243540-93243541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527553646 | chr13:93243541-93243542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140869227 | chr13:93243550-93243551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570655936 | chr13:93243570-93243571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188967431 | chr13:93243587-93243588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377273511 | chr13:93243599-93243600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566122596 | chr13:93243618-93243619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556676991 | chr13:93243623-93243624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs17267214 | chr13:93243648-93243649 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs192531534 | chr13:93243681-93243682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183660828 | chr13:93243682-93243683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572706773 | chr13:93243741-93243742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541358566 | chr13:93243744-93243745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557970744 | chr13:93243763-93243764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577801390 | chr13:93243793-93243794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545525120 | chr13:93243797-93243798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373748876 | chr13:93243798-93243799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562267587 | chr13:93243807-93243808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs11620216 | chr13:93243817-93243818 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs534124638 | chr13:93243856-93243857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs80069440 | chr13:93243895-93243896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200785371 | chr13:93243951-93243952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561477149 | chr13:93243973-93243974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78724684 | chr13:93243974-93243975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
Melanoma | 20877625 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:93237200-93277400 | Weak transcription | Right Atrium | heart |
2 | chr13:93242200-93243600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr13:93242200-93243800 | Enhancers | NH-A | brain |
4 | chr13:93242400-93243000 | Enhancers | NHEK | skin |
5 | chr13:93242600-93243000 | Flanking Active TSS | Hela-S3 | cervix |
6 | chr13:93242600-93243600 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr13:93242600-93243600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr13:93243000-93243600 | Enhancers | Hela-S3 | cervix |
9 | chr13:93249800-93250800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr13:93250800-93251200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
11 | chr13:93251200-93252400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr13:93252400-93254600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
13 | chr13:93254600-93255000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr13:93254600-93255400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr13:93254600-93255400 | Enhancers | NH-A | brain |
16 | chr13:93261800-93263200 | Enhancers | Fetal Intestine Large | intestine |
17 | chr13:93270400-93271600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr13:93271000-93271800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr13:93271000-93272000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr13:93271200-93271800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr13:93287800-93289000 | Enhancers | Fetal Heart | heart |
22 | chr13:93288400-93288800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |